Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Poultry Vaccines Market

Poultry Vaccines Market Trends

Report ID: GMI10613
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Poultry Vaccines Market Trends

The rising demand for poultry products is a major driver of the market, significantly influenced by projections from the Food and Agriculture Organization (FAO) and the Organization for Economic Co-operation and Development (OECD). According to their forecasts, global poultry meat consumption is expected to grow by 15% over the next decade, reaching an estimated 91 million tons by 2032.
With the growing awareness of food safety and quality among consumers adds to the demand for comprehensive poultry health management practices, including vaccination.
As a result, the poultry industry invests more in comprehensive vaccination programs to safeguard the health of their flocks, thereby driving the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Poultry vaccines market was valued at USD 2.3 billion in 2023 and is poised to witness significant growth at 7.1% CAGR during 2024-2032 attributed to the rising demand for poultry products, including meat and eggs, due to population growth.

The attenuated live vaccines segment in the market is anticipated to grow at 6.9% CAGR through 2032 due to its ability to induce a strong and long-lasting immune response.

North America poultry vaccines market is expected to grow at 7% CAGR to reach USD 1.7 billion by 2032 owing to the sophisticated vaccination programs and biosecurity measures.

Biovac, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, and Merck & Co., Inc. among others.